FDA announces test results for eggs on the market, with a failure rate of 14%

The Food and Drug Administration of the Ministry of Health and Welfare yesterday announced the results of random testing of poultry, livestock and aquatic products on the market for residual veterinary drugs carried out by the food and drug inspection brigade in June this year. Of the 86 egg products tested, 12 were found to contain residual veterinary drugs in violation of regulations. Among them, duck eggs were the most numerous with 6 cases, all testing positive for "Lasalocid," which must not be detected. The remaining non-compliant samples were 5 cases of chicken eggs and 1 case of liquid eggs. The sources of these non-compliant egg products have been handed over to agricultural authorities for follow-up (for the detailed product list, please click here)

The FDA pointed out that Lasalocid is a feed additive used as an anticoccidial drug, and exposure to human skin, eyes, or accidental inhalation may cause harm, such as skin inflammation, eye inflammation, or damage to mucosal cells and the upper respiratory tract.

According to the Ministry of Health and Welfare's "Standards for Veterinary Drug Residues," the Lasalocid residue limit in chicken eggs is 0.05 ppm, while duck eggs must have no detectable residue. The U.S. Food and Drug Administration has set the acceptable daily intake (ADI) of Lasalocid at 10 mg per kilogram of body weight per day; for a 60 kg adult, the acceptable daily intake is 600 mg.